TAG:
managed care contract
Competing Against Regional Laboratories
By R. Lewis Dark | From the Volume XIV No. 11 – August 6, 2007 Issue
SINCE THE 1980S, THERE HAS BEEN COMPETITIVE TENSION between publicly traded laboratory companies and their regional counterparts—both independent labs and hospital laboratory outreach programs. It’s an understatement to say that both sectors of the laboratory community often wish the other was no…
BRLI Seizes NYC Share In Two-Stage Effort
By Robert Michel | From the Volume XIV No. 10 – July 16, 2007 Issue
CEO SUMMARY: Bio-Reference Laboratories, Inc., (BRLI) reported record financial results for its most recent fiscal quarter last month. Much of this success is rooted in BRLI’s discipline in defining itself as a local laboratory and using enhanced lab testing services to align itself as …
Exclusive Lab Contracts Have Consequences
By Robert Michel | From the Volume XIV No. 10 – July 16, 2007 Issue
CEO SUMMARY: During the past seven months, competition in the Northeast has intensified. Decisions by UnitedHealth and Aetna to exclude a national laboratory from their respective provider panels has forced many physicians to reconsider their choice of laboratory provider—creating an op…
Intense Competition for Market Share in New York
By R. Lewis Dark | From the Volume XIV No. 10 – July 16, 2007 Issue
ONE OF THE MOST TURBULENT MARKETS FOR LAB SERVICES TODAY is New York City and the Tri-State area of New York, New Jersey, and Connecticut. This is ground zero in the fight for market share between Quest Diagnostics Incorporated and Laboratory Corporation of America a…
Community Hospital Builds Thriving Lab Outreach Program
By Robert Michel | From the Volume XIV No. 8 – June 4, 2007 Issue
CEO SUMMARY: When 330-bed Botsford Hospital of Farmington Hills, Michigan, got interested in laboratory outreach 10 years ago, it brought in a new laboratory leader, invested in new analyzers and informatics, and then let the quality of the operation attract new business from the communit…
Quest Wants It Both Ways with Payer Contracts
By Robert Michel | From the Volume XIV No. 8 – June 4, 2007 Issue
CEO SUMMARY: Once again, public laboratory companies are pursuing short-term strategies that promise competitive advantage to themselves. But these strategies also carry long term risks that could burden the entire laboratory industry. Contradictions in the current cycle of competition fo…
LabCorp & Sunrise CEOs Score at Exec War College
By Robert Michel | From the Volume XIV No. 7 – May 14, 2007 Issue
CEO SUMMARY: This year’s Executive War College on Lab and Pathology Management delivered major surprises, along with first news of breakthrough innovations and emerging trends. Managed care contracting for lab testing services was this year’s premier topic and there was keen interest …
Is There A Power Shift in Pathology?
By R. Lewis Dark | From the Volume XIV No. 6 – April 23, 2007 Issue
SINCE THE END OF WORLD WAR II, the dominant practice model for the pathology profession has been the private group practice. Outside of academia and a few other settings, the vast majority of pathologists practiced laboratory medicine as physician-partners in a medical group. During this same period…
Will OIG Reconsider Policy on Discriminatory Pricing?
By Robert Michel | From the Volume XIV No. 5 – April 2, 2007 Issue
HEIGHTENED COMPETITION in recent months for exclusive managed care contracts between the two blood brothers may trigger the law of unintended consequences. One such consequence could be renewed interest by Medicare regulators in what they call “discriminatory billing.” “In 2003, the federal …
Labs Can Be Misguided by Pull-Through Test Myth
By Robert Michel | From the Volume XIV No. 5 – April 2, 2007 Issue
CEO SUMMARY: For the first time in almost eight years, there are major disruptions to the status quo in managed care contracting for laboratory testing services. As was true in the 1990s, national lab companies are pursuing exclusive national contracts with the nation’s…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized